The U.S. Food and Drug Administration granted orphan drug designation to Acucela's leading drug candidate emixustat hydrochloride, which was created to treat Stargardt disease. Read More »

Dova Pharmaceuticals Inc., a clinical, late-stage company, recently named Alex Sapir as its new CEO. Read More »

Amorsa Therapeutics, a neuropharmaceutical company specializing in treating nervous system disorders, has entered a partnership with Janssen Pharmaceuticals Inc. Read More »

Ionis Pharmaceuticals Inc. and Akcea Therapeutics, an Ionis subsidiary, recently announced a partnership with Novartis to develop and commercialize the drugs AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx. Read More »

Dr. Ciara Kennedy has been named president and chief executive officer of Amplyx Pharmaceuticals, a company that develops novel antifungal agents for life-threatening fungal infections. Read More »

Expanding their existing relationship, Community Health Network will manage 12 retail health clinics in Walgreens stores across central Indiana. Read More »

Iroko Pharmaceuticals LLC, a company focused on advancing the science of analgesia, recently received a patent for VIVLODEX (meloxicam) capsules 5 mg and 10 mg. Read More »

The Centers for Disease Control and Prevention (CDC) recently announced 10 critical contributions toward the fight against the Zika virus in 2016. Read More »

RxWiki Inc. has launched Patient Verified Reviews, a platform that allows patients to rate their pharmacy. Read More »

EnteroMedics Inc. has retired its Senior Amortizing Convertible Notes, converted all $18.75 million in notes to shares of common stock, as part of a strategy to regain compliance with the Nasdaq requirement that it have a minimum of $2.5 million of stockholders’ equity. Read More »

Dr. Dan Iosifescu, a well-known clinician-specialist specializing in mood disorders, has joined NYU Langone Medical Center's psychiatry faculty. Read More »

Sanofi's Soliqua 100/33 product to treat adults with Type 2 diabetes is now available via prescription in U.S. pharmacies. Read More »

MiMedx Group Inc. has filed lawsuits against two former sales employees for alleged breaches of contractual and common law obligations. Read More »

CVS Health Corp. President and CEO Larry Merlo spoke to investors this week at the 35th Annual J.P. Morgan Healthcare Conference. Read More »

The pharmaceutical research company TPD LLC (Trends in Pharma Development) recently announced its new line of PanX medicines for use in treating anxiety. The products will be available nationwide as prescription compounded drugs. Read More »

Factor One Source Pharmacy, a specialty pharmacy that serves individuals with complex or hard-to-manage medications, will acquire Fast Access Specialty Therapeutics, a quickly growing pharmacy that has made a name for itself through industry-leading customer satisfaction, patient engagement and strong financial performance. Read More »

Bayer AG and Versant Ventures recently announced a partnership to launch BlueRock Therapeutics. The joint venture will utilize breakthrough treatments in stem cell technology to cure a range of diseases. Read More »

Bayer recently announced the selection of Robert LaCaze as executive vice president in charge of the company’s new Oncology Strategic Business Unit at the Pharmaceuticals Division. Read More »

AcelRX Pharmaceuticals recently submitted a new drug application to the U.S. Food and Drug Administration for ARX-04. Read More »

CVS Health recently launched Transform Diabetes Care, a program dedicated to helping clients improve member health outcomes. Read More »